mGluR1 Antibody (YA3195)
(Synonyms: GRM1; GPRC1A; MGLUR1; Metabotropic glutamate receptor 1; mGluR1)Based on 1 Customer Validation
mGluR1 Antibody (YA3195) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to mGluR1.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
|---|---|
| Dilution Ratio | 1:500-1:1000 |
Product Details
mGluR1 Antibody (YA3195) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to mGluR1.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 101 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 132 kDa
Entrez Gene: 2911 Human ; 14816 Mouse ; 24414 Rat
SwissProt: Q13255 Human ; P97772 Mouse ; P23385 Rat
OMIM: 614831 Human
A synthesized peptide derived from human mGluR1 aa315-385.
Endogenous
Affinity Chromatography
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
The metabotropic glutamate receptor subtype 1 (mGluR1) is a G-protein coupled receptor that mediates excitatory neurotransmission by activating phospholipase C and subsequent intracellular Ca2+ signaling[1][2]. Mechanistically, mGluR1 primarily couples to the Gq/11 family, leading to inositol trisphosphate (IP3) -dependent Ca2+ release and modulation of postsynaptic excitability[3][4]. In cerebellar Purkinje cells, mGluR1a, the predominant isoform, localizes perisynaptically and facilitates long-term depression (LTD) and climbing fiber synapse elimination, whereas the shorter mGluR1b lacks the extended C-terminal domain, resulting in dispersed subcellular distribution and altered IP3R-mediated Ca2+ signaling[1]. Compared with mGluR5, mGluR1 exhibits distinct pharmacology, including selective sensitivity to non-competitive antagonists like cyclothiazide and agonist potency dependent on the C-terminal domain[5][6]. In experimental disease models, mGluR1 expression is dynamically regulated in neurodegeneration and stress paradigms, contributing to synaptic plasticity deficits, excitotoxicity, and hippocampal signaling alterations[7][8]. Agonists and allosteric modulators of mGluR1 have been utilized to investigate synaptic transmission, motor coordination, and learning in rodent models, with subtype-selective agents enabling differentiation from mGluR5-mediated effects[9][10]. These characteristics make mGluR1 a critical target for dissecting group I mGluR function, understanding isoform-specific signaling, and designing pharmacological interventions in central nervous system studies[1][2][5].
-
Subcellular Localization
Cell membrane; Multi-pass membrane protein; Postsynaptic cell membrane; Multi-pass membrane protein; Cell projection, dendrite
-
Expression
Tissue_specificity:Detected in brain -
Isoforms & Post-Translational Modification
Q13255 has 3 isomers: Q13255-1: 132357 Da (predicted); Q13255-2: 101323 Da (predicted); Q13255-3: 101473 Da (predicted).
-
Subunit
Homodimer; disulfide-linked (PubMed:24603153).
-
SwissProt ID
-
Synonyms
GRM1; GPRC1A; MGLUR1; Metabotropic glutamate receptor 1; mGluR1
-
Research Field
Neuroscience
Documentation
-
Data Sheet (262 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
User Guide for Antibodies (1077 KB)
References
[1]. Ohtani Y, et al. The synaptic targeting of mGluR1 by its carboxyl-terminal domain is crucial for cerebellar function. J Neurosci. 2014 Feb 12;34(7):2702-12. [Content Brief]
[2]. Flor PJ, et al. The C-terminal domain of the mGluR1 metabotropic glutamate receptor affects sensitivity to agonists. J Neurochem. 1996 Jul;67(1):58-63. [Content Brief]
[3]. Kumpost J, et al. Surface expression of metabotropic glutamate receptor variants mGluR1a and mGluR1b in transfected HEK293 cells. Neuropharmacology. 2008 Sep;55(4):409-18. [Content Brief]
[4]. Sun YG, et al. mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus. J Neurosci. 2016 Jul 27;36(30):7886-96. [Content Brief]
[5]. Surin A, et al. Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists. Neuropharmacology. 2007 Mar;52(3):744-54. [Content Brief]
[6]. Mary S, et al. A cluster of basic residues in the carboxyl-terminal tail of the short metabotropic glutamate receptor 1 variants impairs their coupling to phospholipase C. J Biol Chem. 1998 Jan 2;273(1):425-32. [Content Brief]
[7]. Dyka FM, et al. Metabotropic glutamate receptors are differentially regulated under elevated intraocular pressure. J Neurochem. 2004 Jul;90(1):190-202. [Content Brief]
[8]. Wierońska JM, et al. Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus. Pharmacol Rep. 2008 Nov-Dec;60(6):844-55. [Content Brief]
[9]. Gereau RW 4th, et al. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J Neurosci. 1995 Oct;15(10):6879-89. [Content Brief]
[10]. Harbers M, et al. mGluR5 Is Substitutable for mGluR1 in Cerebellar Purkinje Cells for Motor Coordination, Developmental Synapse Elimination, and Motor Learning. Cells. 2022 Jun 23;11(13):2004. [Content Brief]